Search - tctmd.com

Displaying 21 - 40 of 49

Sort: Relevancy | Date

News Conference News ISET 2017

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Caitlin E. Cox

February 10, 2017

News Conference News ISET 2017

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

Caitlin E. Cox

February 07, 2017

News Features

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

Shelley Wood

December 30, 2016

News Daily News

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Shelley Wood

October 07, 2016

News Daily News

Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática

Shelley Wood

October 07, 2016

News Industry News

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

July 08, 2016

News Industry News

Shockwave Medical Announces Positive Study Results of Novel Lithoplasty System to Treat Peripheral Artery Disease

April 27, 2016

News Industry News

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

April 22, 2016

News Industry News

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

April 07, 2016

News Conference News ISET 2016

Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions

Michael O'Riordan

February 15, 2016

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Un Meta Análisis Avala el Mayor Uso del Abordaje Radial

November 29, 2015

News Daily News

Meta-Analysis Boosts Case for Increased Use of Radial Access

November 29, 2015

News Daily News

Paradoja Campeau: ¿Sacrifica el Abordaje Radial la Competencia Femoral?

L.A. McKeown

November 24, 2015

News Daily News

Campeau Paradox: Is Femoral Proficiency Lost When Radial Access Thrives?

L.A. McKeown

November 24, 2015

News Industry News

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

October 27, 2015

News Daily News

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

May 30, 2014

News Daily News

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

Jason Kahn

February 20, 2014

News Daily News

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Jason Kahn

February 20, 2014

Presentation

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Presenter: Martin Werner

February 19, 2014

Advertisement

Percutaneous Bypass for Long, Complex SFA Lesions Holds Up Well to 6 Months: DETOUR I Study

Positive 6-Month Outcomes Seen With Endovascular Therapy for Symptomatic PAD: LIBERTY 360

全年回顾：医生选出介入心脏病学等领域 2016 年的最大新闻

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática

Essential Medical Inc. Announces FDA Approval to Begin a U.S. Clinical Trial for the MANTA™ Large Bore Vascular Closure Device

Shockwave Medical Announces Positive Study Results of Novel Lithoplasty System to Treat Peripheral Artery Disease

VENITI® Completes First Use Of VICI VERTO VENOUS STENT™, Novel Venous Stent System

CARDIONOVUM Announces Enrollment of First Patient in MAGNIFICENT Trial

Investigational Metallic-Tipped Catheter Shows Early PAD Promise in CTOs, Calcified Lesions

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Un Meta Análisis Avala el Mayor Uso del Abordaje Radial

Meta-Analysis Boosts Case for Increased Use of Radial Access

Paradoja Campeau: ¿Sacrifica el Abordaje Radial la Competencia Femoral?

Campeau Paradox: Is Femoral Proficiency Lost When Radial Access Thrives?

Symic Biomedical Advances First Product Candidate, SB-030, into Clinical Development with Treatment of First Patient in SHIELD Trial

ILLUMENATE First-in-Human Study: Novel Drug-Coated Balloon Yields Strong 2-Year Outcomes in SFA Lesions

Un Stent Bioabsorbible de 1ª Generación Funciona Bien en Lesiones de la AFS

First-Generation Bioresorbable Stent Performs Well in SFA Lesions

Evaluation of the Biodegradable Peripheral Igaki-Tamai Stent in the Treatment of SFA de novo Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content